Genetic determinants of treatment benefit of the angiotensin-converting enzyme-inhibitor perindopril in patients with stable coronary artery disease (Q43031194)

From Wikidata

Jump to navigation Jump to search

scientific article published on 10 June 2010

Language	Label	Description	Also known as
English	Genetic determinants of treatment benefit of the angiotensin-converting enzyme-inhibitor perindopril in patients with stable coronary artery disease	scientific article published on 10 June 2010

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Genetic determinants of treatment benefit of the angiotensin-converting enzyme-inhibitor perindopril in patients with stable coronary artery disease (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

1 reference

based on heuristic

inferred from title

3

object named as

Eric Boersma

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

object named as

Claudio Ceconi

9

0 references

object named as

John Chalmers

10

0 references

Maarten L Simoons

16

object named as

Maarten L Simoons

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Jacqueline C M Witteman

14

object named as

Jacqueline C M Witteman

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Toshiharu Ninomiya

8

object named as

Toshiharu Ninomiya

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

André Uitterlinden

5

object named as

Andre G Uitterlinden

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Stephen MacMahon

11

object named as

Stephen MacMahon

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

2

object named as

Aaron Isaacs

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Willem J. Remme

6

object named as

Willem Remme

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Moniek P M de Maat

17

object named as

Moniek P M de Maat

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

author name string

Jasper Jan Brugts

1

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Cock M van Duijn

4

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Michel Bertrand

7

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Kim Fox

12

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Roberto Ferrari

13

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

A H Jan Danser

15

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

publication date

10 June 2010

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

European Heart Journal

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

31

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

15

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

1854-1864

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Angiotensin-converting-enzyme inhibitors in stable vascular disease without left ventricular systolic dysfunction or heart failure: a combined analysis of three trials

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ169

21 January 2018

Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study).

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ169

21 January 2018

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ169

21 January 2018

Angiotensin-converting-enzyme inhibition in stable coronary artery disease

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ169

21 January 2018

Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ169

21 January 2018

ACC/AHA 2002 guideline update for the management of patients with chronic stable angina--summary article: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on the Management of Pat

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ169

21 January 2018

Treatment benefit by perindopril in patients with stable coronary artery disease at different levels of risk

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ169

21 January 2018

The cardioprotective effects of the angiotensin-converting enzyme inhibitor perindopril in patients with stable coronary artery disease are not modified by mild to moderate renal insufficiency: insights from the EUROPA trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ169

21 January 2018

Secondary prevention of coronary disease with ACE inhibition--does blood pressure reduction with perindopril explain the benefits in EUROPA?

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ169

21 January 2018

The consistency of the treatment effect of an ACE-inhibitor based treatment regimen in patients with vascular disease or high risk of vascular disease: a combined analysis of individual data of ADVANCE, EUROPA, and PROGRESS trials

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ169

21 January 2018

Renin-angiotensin system gene polymorphisms: potential mechanisms for their association with cardiovascular diseases

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ169

21 January 2018

The EUROPA trial: design, baseline demography and status of the substudies

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ169

21 January 2018

The rationale and design of the PERindopril GENEtic association study (PERGENE): a pharmacogenetic analysis of angiotensin-converting enzyme inhibitor therapy in patients with stable coronary artery disease

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ169

21 January 2018

Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ169

21 January 2018

Logistics and quality control for DNA sampling in large multicenter studies.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ169

21 January 2018

Efficiency and power in genetic association studies

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ169

21 January 2018

Score tests for association between traits and haplotypes when linkage phase is ambiguous

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ169

21 January 2018

Methods for meta-analysis in genetic association studies: a review of their potential and pitfalls

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ169

21 January 2018

Genetic determinants of response to clopidogrel and cardiovascular events

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ169

21 January 2018

SLCO1B1 variants and statin-induced myopathy--a genomewide study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ169

21 January 2018

Estimation of the warfarin dose with clinical and pharmacogenetic data

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ169

21 January 2018

Pharmacogenetics of ACE inhibition in stable coronary artery disease: steps towards tailored drug therapy

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ169

21 January 2018

ACE phenotyping as a first step toward personalized medicine for ACE inhibitors. Why does ACE genotyping not predict the therapeutic efficacy of ACE inhibition?

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ169

21 January 2018

The ACE gene I/D polymorphism is not associated with the blood pressure and cardiovascular benefits of ACE inhibition

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ169

21 January 2018

Pharmacogenetic association of the angiotensin-converting enzyme insertion/deletion polymorphism on blood pressure and cardiovascular risk in relation to antihypertensive treatment: the Genetics of Hypertension-Associated Treatment (GenHAT) study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ169

21 January 2018

Homogeneous assay of rs4343, an ACE I/D proxy, and an analysis in the British Women's Heart and Health Study (BWHHS).

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ169

21 January 2018

The kinin B1 receptor contributes to the cardioprotective effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in mice

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ169

21 January 2018

Novel mode of action of angiotensin I converting enzyme inhibitors: direct activation of bradykinin B1 receptor

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ169

21 January 2018

Kinin B1 receptors stimulate nitric oxide production in endothelial cells: signaling pathways activated by angiotensin I-converting enzyme inhibitors and peptide ligands

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ169

21 January 2018

Do angiotensin-converting enzyme inhibitors directly stimulate the kinin B1 receptor?

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ169

21 January 2018

Blockade of bradykinin receptor B1 but not bradykinin receptor B2 provides protection from cerebral infarction and brain edema

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ169

21 January 2018

Angiotensin-converting enzyme inhibition in cardiovascular disease: evidence with perindopril

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ169

21 January 2018

Identifiers

10.1093/EURHEARTJ/EHQ169

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43031194&oldid=1977644561"